ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
PAVmed Inc

PAVmed Inc (PAVM)

0.621
-0.027
( -4.17% )
업데이트: 00:33:02

실시간 토론 및 거래 아이디어: 강력한 플랫폼으로 자신있게 거래하세요.

주요 통계 및 세부정보

가격
0.621
매수가
0.635
매도가
0.6466
거래량
14,355
0.621 일간 변동폭 0.648
0.5719 52주 범위 3.50
market_cap
전일 종가
0.648
개장가
0.64
최근 거래 시간
11
@
0.630343
마지막 거래 시간
00:24:55
재정 규모
US$ 9,071
VWAP
0.631919
평균 볼륨(3m)
175,926
발행 주식
11,068,566
배당수익률
-
주가수익률
-0.11
주당순이익(EPS)
-5.99
매출
2.45M
순이익
-66.27M

PAVmed Inc 정보

PAVmed Inc is a medical device company engaged in advancing a pipeline of medical technologies from concept to commercialization using a business model focused on capital and time efficiency. Its product includes EsoCheck; CarpX; EsoGuard; PortIO; DisappEAR and others. PAVmed Inc is a medical device company engaged in advancing a pipeline of medical technologies from concept to commercialization using a business model focused on capital and time efficiency. Its product includes EsoCheck; CarpX; EsoGuard; PortIO; DisappEAR and others.

섹터
Surgical,med Instr,apparatus
산업
Surgical,med Instr,apparatus
웹사이트
본부
Wilmington, Delaware, USA
설립됨
-
PAVmed Inc is listed in the Surgical,med Instr,apparatus sector of the 나스닥 with ticker PAVM. The last closing price for PAVmed was US$0.65. Over the last year, PAVmed shares have traded in a share price range of US$ 0.5719 to US$ 3.50.

PAVmed currently has 11,068,566 shares in issue. The market capitalisation of PAVmed is US$7.17 million. PAVmed has a price to earnings ratio (PE ratio) of -0.11.

PAVM 최신 뉴스

Lucid Diagnostics Announces Record Quarterly EsoGuard® Test Volume

Lucid Diagnostics Announces Record Quarterly EsoGuard® Test Volume PR Newswire NEW YORK, Jan. 13, 2025 Quarterly test volume of over 4,000 tests represented sequential increase of 45 percent NEW...

Lucid Diagnostics Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule

Lucid Diagnostics Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule PR Newswire NEW YORK, Dec. 23, 2024 NEW YORK, Dec. 23, 2024 /PRNewswire/ -- Lucid...

Lucid Diagnostics Partners with VITALExam to Enhance Esophageal Precancer Detection for Firefighters

Lucid Diagnostics Partners with VITALExam to Enhance Esophageal Precancer Detection for Firefighters PR Newswire NEW YORK, Dec. 19, 2024 Partnership launched with fully-contracted...

Prospective Clinical Utility Study of Lucid Diagnostics' EsoGuard® Esophageal DNA Test Accepted for Peer-Reviewed Publication

Prospective Clinical Utility Study of Lucid Diagnostics' EsoGuard® Esophageal DNA Test Accepted for Peer-Reviewed Publication PR Newswire NEW YORK, Dec. 11, 2024 Study demonstrates outstanding...

Lucid Diagnostics Completes Convertible Debt Refinancing to Strengthen Balance Sheet and Extend Cash Runway Past Key Near-Term Milestones

Lucid Diagnostics Completes Convertible Debt Refinancing to Strengthen Balance Sheet and Extend Cash Runway Past Key Near-Term Milestones PR Newswire NEW YORK, Dec. 3, 2024 New convertible debt...

Lucid Diagnostics Submits Clinical Evidence Package to MolDX Seeking Medicare Coverage for EsoGuard® Esophageal DNA Test

Lucid Diagnostics Submits Clinical Evidence Package to MolDX Seeking Medicare Coverage for EsoGuard® Esophageal DNA Test PR Newswire NEW YORK, Nov. 20, 2024 NEW YORK, Nov. 20, 2024 /PRNewswire/...

Lucid Diagnostics to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

Lucid Diagnostics to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum PR Newswire NEW YORK, Nov. 18, 2024 NEW YORK, Nov. 18, 2024 /PRNewswire/...

PAVmed Provides Business Update and Third Quarter 2024 Financial Results

PAVmed Provides Business Update and Third Quarter 2024 Financial Results PR Newswire NEW YORK, Nov. 14, 2024 Lucid reports record quarterly EsoGuard® revenue and completes clinical evidence...

Lucid Diagnostics' ESOGUARD BE-1 Prospective Multicenter Clinical Validation Study of EsoGuard® Esophageal Precancer Testing Accepted for Peer-Reviewed Publication

Lucid Diagnostics' ESOGUARD BE-1 Prospective Multicenter Clinical Validation Study of EsoGuard® Esophageal Precancer Testing Accepted for Peer-Reviewed Publication PR Newswire NEW YORK, Nov. 7...

Lucid Diagnostics Expands Direct Contracting Initiative with Multiple Programs Focused on Near-Term Revenue Drivers

Lucid Diagnostics Expands Direct Contracting Initiative with Multiple Programs Focused on Near-Term Revenue Drivers PR Newswire NEW YORK, Nov. 5, 2024 Industry veterans from leading cancer...

기간변동변동 %시가고가저가평균 일일 거래량VWAP
1-0.038-5.766312594840.6590.680.57192451490.63644287CS
4-0.049-7.313432835820.670.760.57192453480.64694591CS
12-0.409-39.70873786411.031.250.57191759260.74165328CS
26-0.379-37.911.90.57191123440.87287307CS
52-1.709-73.3476394852.333.50.5719888221.20982396CS
156-22.779-97.346153846223.435.10.571958073014.05860404CS
260-21.579-97.202702702722.2145.50.5719114811247.88176448CS

PAVM - Frequently Asked Questions (FAQ)

What is the current PAVmed share price?
The current share price of PAVmed is US$ 0.621
How many PAVmed shares are in issue?
PAVmed has 11,068,566 shares in issue
What is the market cap of PAVmed?
The market capitalisation of PAVmed is USD 7.17M
What is the 1 year trading range for PAVmed share price?
PAVmed has traded in the range of US$ 0.5719 to US$ 3.50 during the past year
What is the PE ratio of PAVmed?
The price to earnings ratio of PAVmed is -0.11
What is the cash to sales ratio of PAVmed?
The cash to sales ratio of PAVmed is 2.89
What is the reporting currency for PAVmed?
PAVmed reports financial results in USD
What is the latest annual turnover for PAVmed?
The latest annual turnover of PAVmed is USD 2.45M
What is the latest annual profit for PAVmed?
The latest annual profit of PAVmed is USD -66.27M
What is the registered address of PAVmed?
The registered address for PAVmed is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the PAVmed website address?
The website address for PAVmed is www.pavmed.com
Which industry sector does PAVmed operate in?
PAVmed operates in the SURGICAL,MED INSTR,APPARATUS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
GITSGlobal Interactive Technologies Inc
US$ 1.95
(1,904.11%)
16.36k
YIBOPlanet Image International Ltd
US$ 7.25
(237.21%)
1.82M
JGAurora Mobile Ltd
US$ 16.37
(172.28%)
20.86M
AKROAkero Therapeutics Inc
US$ 53.43
(104.09%)
8.54M
HWHHWH International Inc
US$ 0.523
(81.79%)
102.04M
ALLKAllakos Inc
US$ 0.272
(-77.52%)
18.49M
VERUVeru Inc
US$ 0.6513
(-46.17%)
21.92M
NXUNXU Inc
US$ 0.3532
(-42.66%)
3.05M
ELABPMGC Holdings Inc
US$ 1.975
(-36.29%)
2.52M
NBISNebius Group NV
US$ 28.64
(-31.30%)
16.07M
NVDANVIDIA Corporation
US$ 123.3284
(-13.53%)
214.49M
ONCOOnconetix Inc
US$ 0.8112
(69.00%)
149.35M
HOLOMicroCloud Hologram Inc
US$ 1.9495
(25.77%)
139.95M
HWHHWH International Inc
US$ 0.52485
(82.43%)
102.06M
RIMEAlgorhythm Holdings Inc
US$ 0.0348
(-7.94%)
57.52M

PAVM Discussion

게시물 보기
Monksdream Monksdream 7 월 전
PAVM under $2
👍️0
Monksdream Monksdream 12 월 전
PAVM new 52 week low
👍️0
Monksdream Monksdream 1 년 전
PAVM new 52 week low
👍️0
Mattrixinvest Mattrixinvest 1 년 전
Boom
👍️0
Monksdream Monksdream 1 년 전
PAVM new 52 week low
👍️0
Porterhouse10 Porterhouse10 3 년 전
Boom! Haaa
👍️0
Thunderstruck Thunderstruck 3 년 전
PAVM....Why the drop?? wasn't there just good news out in regards to this company and Lucid??
👍️0
Prfmf1 Prfmf1 3 년 전
Looks like they are trying to keep the stock around or under $7.50 to burn the August 20 options holders.
👍️0
TrendTrade2016 TrendTrade2016 4 년 전
not bullish...but bouncing. No microcaps are bullish right now...play with caution!!!
👍️0
TommyBoyTrader9460 TommyBoyTrader9460 4 년 전
$PAVM Chart looking bullish here..
https://twitter.com/QuabbinR/status/1419357207557193733?s=20
👍️0
SurgeGuy2.0 SurgeGuy2.0 4 년 전
Was the CEO really arrested last week for fraud? Would it be the first time? Need to do a little more looking at it....right?
👍️0
SurgeGuy2.0 SurgeGuy2.0 4 년 전
Looking good like a stinky pile of crap. PAVM is going nowhere! lolzzzzzzzz
👍️0
bUrRpPPP! bUrRpPPP! 4 년 전
Looking good!
👍️0
Prfmf1 Prfmf1 4 년 전
What are your expectations going forward?
👍️0
TrendTrade2016 TrendTrade2016 4 년 전
PAVM there's a monster breaking out of its chains!!
👍️0
Prfmf1 Prfmf1 4 년 전
Short time PAVM holder and looking for big things to happen with this stock. My average buying price is in the low 4's.
👍️0
Flycanuck Flycanuck 4 년 전
Thanks for the tip. Will have a look .
👍️0
Flycanuck Flycanuck 4 년 전
Got Z warrants and shares too. Have not sold yet. Holding through this run up.
👍️0
rumrunner528 rumrunner528 4 년 전
Thank you, ConstitutionNow.

rum
👍️0
ConstitutionNow ConstitutionNow 4 년 전
Visit stocktwits.com at all? Lots of long term holders on there that have a good pulse on what's happening. I know Lucid spinoff is in the works, 3 clinics in phoenix about to open for eso testing. Eso 'in stock' at like 180 clinics around US. Do some quick numbers on a each test and you can see revs could scale quickly. Throw in nexflo, carpx etc and pavmed could be a great long term investment.
👍️0
rumrunner528 rumrunner528 4 년 전
Good for you, ConstitutionNow. I have z's and shares and have been lightening my position as it's run up. I wish I knew what's going on other than the recent PRs.

rum
👍️0
ConstitutionNow ConstitutionNow 4 년 전
Need a message at the top other than Clay...bad luck anytime he posts. Still sittin on a pile of z warrants...very bright future here! Eso, carpx etc...
👍️0
ClayTrader ClayTrader 4 년 전
* * $PAVM Video Chart 04-06-2021 * *

Link to Video - click here to watch the technical chart video

👍️0
Bertsllc Bertsllc 4 년 전
Cantor Fitzgerald analysis upgraded PAVM to overweight with the new target of $8.00.

https://www.benzinga.com/news/21/03/20397441/cantor-fitzgerald-initiates-coverage-on-pavmed-with-overweight-rating-announces-price-target-of-8

👍️0
ConstitutionNow ConstitutionNow 4 년 전
Little late in response here, but good analysis of the latest money raise. Solid move by management to get debt off books, lower dilution and cash leftover to fund commercialization. I think the market is starting to realize it now and we should move north on much more solid ground...where they can raise more cash at prices which don't hurt so much.
👍️0
Flycanuck Flycanuck 4 년 전
from the March 2020 S-3A (link below - page 5), I counted about 14 million shares could have been issued by the convertibles. So actually longer term they have about 4 million shares LESS outstanding plus all the cash you mentioned above. Win / Win.
https://www.sec.gov/Archives/edgar/data/1624326/000149315220005215/forms-3a.htm
👍️0
Flycanuck Flycanuck 4 년 전
"PAVmed intends to use the net proceeds from the offering to repay all of the company’s outstanding debt, including all outstanding convertible notes, with the balance to be used for working capital and general corporate purposes."

People don't realize, this doesn't increase dilution. It's a near wash in shares added, becasue the outstanding convertible shares are taken off the books by paying off the convertible holders. It increases float, but not outstanding.

Then the proceeds pay off all other debt, and the company still has around 30M from the offering to use for operations. It's a huge win for the company and shareholders.
👍️0
ClayTrader ClayTrader 4 년 전
* * $PAVM Video Chart 02-22-2021 * *

Link to Video - click here to watch the technical chart video

👍️0
tone3 tone3 4 년 전
Must read article on Seeking Alpha. Target prices from a low of 5.50 up to 12 bucks
👍️0
ConstitutionNow ConstitutionNow 4 년 전
No odea what you are talking about...posted on twitter???????????
👍️0
SurgeGuy2.0 SurgeGuy2.0 4 년 전
When will the new Offering/Dilution for 2021 be announced?

Saw it posted on twitter
👍️0
rumrunner528 rumrunner528 4 년 전
Thank you.
👍️0
ConstitutionNow ConstitutionNow 4 년 전
I've dug into those a bit, from what I can tell they are exercisable at a $1.60 a common share. Expire 2024. Slightly more risky than common but not much, if only one of their products take off, imo the warrants are much better investment dollar for dollar.
👍️0
rumrunner528 rumrunner528 4 년 전
👍️0
rumrunner528 rumrunner528 4 년 전
Does anyone know the terms of the PAVMZ warrants? The 10K is very confusing (or perhaps I'm just not that bright).
👍️0
jaj-dan jaj-dan 5 년 전
Gaining lots of credibility here.
👍️0
jaj-dan jaj-dan 5 년 전
PAVmed to join key indexes this month, shares +5% https://seekingalpha.com/news/3583795-pavmed-to-join-key-indexes-this-month-sharesplus-5
👍️0
jaj-dan jaj-dan 5 년 전
News from yesterday. Probably why the price is moving up.

Founder and Former Chairman & CEO of Exact Sciences Stanley Lapidus Joins PAVmed Subsidiary Lucid Diagnostics as Strategic Advisor https://seekingalpha.com
👍️0
jaj-dan jaj-dan 5 년 전
I was just repeating the talking points from the conference call.
👍️0
Bickema Bickema 5 년 전
"PAVmed had cash and cash equivalents of $8.7 million as of March 31, 2020, compared with $6.2 million as of December 31, 2019. Subsequently, in late April 2020, the Company received approximately $3.6 million in proceeds from a private placement with an institutional investor for the sale of a Senior Secured Convertible Note."

Looks like they $12 million in cash no?
👍️0
Cubzgrl Cubzgrl 5 년 전
Moving north!!!! Lets get back to the $6.00s lol
👍️0
jaj-dan jaj-dan 5 년 전
https://ir.pavmed.com/news-events/press-releases/detail/121/pavmed-collaborates-with-canon-on-disappear-pediatric
👍️0
jaj-dan jaj-dan 5 년 전
PAVMed Is About To Enter The Commercialization Phase https://seekingalpha.com/article/4350867-pavmed-is-to-enter-commercialization-phase
👍️0
tjguy tjguy 5 년 전
Is the European approval of CarpX coming up soon?
👍️0
jaj-dan jaj-dan 5 년 전
I don’t really care if it dips here. There’s plenty of firms targeting this at $9-$10. It’s one of my best positions at the moment. I’m holding.
👍️0
jaj-dan jaj-dan 5 년 전
They didn’t really have much to say on the call. They were impacted by the virus with elective surgeries being postponed. They also commented that esoguard could be spun off into another company to raise money
👍️0
jaj-dan jaj-dan 5 년 전
There was only 1 analyst on the call. That’s not good. Management sounded very competent answering questions
👍️0
elcheepo elcheepo 5 년 전
thats a lot of cash they burned... they need to slow down
👍️0
jaj-dan jaj-dan 5 년 전
They said that their CarpX device will make 80-85% return
👍️0
jaj-dan jaj-dan 5 년 전
Re: PAVM
Some people may have bought hoping for a partnership deal announced. These things take time. You won't get a great deal if you are in a hurry.
👍️0

최근 히스토리

Delayed Upgrade Clock